The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global Mesalazine market was valued at US$ 161.8 million in 2023 and is anticipated to reach US$ 223.5 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Global key players of Mesalazine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
This report aims to provide a comprehensive presentation of the global market for Mesalazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalazine.
Report Scope
The Mesalazine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mesalazine market comprehensively. Regional market sizes, concerning products by Purity, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalazine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Purity, by Application, and by regions.
Market Segmentation
By Company
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Segment by Purity
Above 97 %
Above 98 %
Above 99 %
Segment by Application
Tablets
Capsules
Pellet and Granule
Suppository
Enema
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Purity, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mesalazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mesalazine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global Mesalazine market was valued at US$ 161.8 million in 2023 and is anticipated to reach US$ 223.5 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Global key players of Mesalazine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
This report aims to provide a comprehensive presentation of the global market for Mesalazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalazine.
Report Scope
The Mesalazine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mesalazine market comprehensively. Regional market sizes, concerning products by Purity, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalazine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Purity, by Application, and by regions.
Market Segmentation
By Company
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Segment by Purity
Above 97 %
Above 98 %
Above 99 %
Segment by Application
Tablets
Capsules
Pellet and Granule
Suppository
Enema
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Purity, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mesalazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mesalazine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Mesalazine Market Overview
1.1 Product Overview and Scope of Mesalazine
1.2 Mesalazine Segment by Purity
1.2.1 Global Mesalazine Market Value Comparison by Purity (2024-2030)
1.2.2 Above 97 %
1.2.3 Above 98 %
1.2.4 Above 99 %
1.3 Mesalazine Segment by Application
1.3.1 Global Mesalazine Market Value by Application: (2024-2030)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Pellet and Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Global Mesalazine Market Size Estimates and Forecasts
1.4.1 Global Mesalazine Revenue 2019-2030
1.4.2 Global Mesalazine Sales 2019-2030
1.4.3 Global Mesalazine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mesalazine Market Competition by Manufacturers
2.1 Global Mesalazine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mesalazine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mesalazine Average Price by Manufacturers (2019-2024)
2.4 Global Mesalazine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mesalazine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mesalazine, Product Type & Application
2.7 Mesalazine Market Competitive Situation and Trends
2.7.1 Mesalazine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mesalazine Players Market Share by Revenue
2.7.3 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mesalazine Retrospective Market Scenario by Region
3.1 Global Mesalazine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mesalazine Global Mesalazine Sales by Region: 2019-2030
3.2.1 Global Mesalazine Sales by Region: 2019-2024
3.2.2 Global Mesalazine Sales by Region: 2025-2030
3.3 Global Mesalazine Global Mesalazine Revenue by Region: 2019-2030
3.3.1 Global Mesalazine Revenue by Region: 2019-2024
3.3.2 Global Mesalazine Revenue by Region: 2025-2030
3.4 North America Mesalazine Market Facts & Figures by Country
3.4.1 North America Mesalazine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mesalazine Sales by Country (2019-2030)
3.4.3 North America Mesalazine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mesalazine Market Facts & Figures by Country
3.5.1 Europe Mesalazine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mesalazine Sales by Country (2019-2030)
3.5.3 Europe Mesalazine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mesalazine Market Facts & Figures by Country
3.6.1 Asia Pacific Mesalazine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mesalazine Sales by Country (2019-2030)
3.6.3 Asia Pacific Mesalazine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mesalazine Market Facts & Figures by Country
3.7.1 Latin America Mesalazine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mesalazine Sales by Country (2019-2030)
3.7.3 Latin America Mesalazine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mesalazine Market Facts & Figures by Country
3.8.1 Middle East and Africa Mesalazine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mesalazine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mesalazine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Purity
4.1 Global Mesalazine Sales by Purity (2019-2030)
4.1.1 Global Mesalazine Sales by Purity (2019-2024)
4.1.2 Global Mesalazine Sales by Purity (2025-2030)
4.1.3 Global Mesalazine Sales Market Share by Purity (2019-2030)
4.2 Global Mesalazine Revenue by Purity (2019-2030)
4.2.1 Global Mesalazine Revenue by Purity (2019-2024)
4.2.2 Global Mesalazine Revenue by Purity (2025-2030)
4.2.3 Global Mesalazine Revenue Market Share by Purity (2019-2030)
4.3 Global Mesalazine Price by Purity (2019-2030)
5 Segment by Application
5.1 Global Mesalazine Sales by Application (2019-2030)
5.1.1 Global Mesalazine Sales by Application (2019-2024)
5.1.2 Global Mesalazine Sales by Application (2025-2030)
5.1.3 Global Mesalazine Sales Market Share by Application (2019-2030)
5.2 Global Mesalazine Revenue by Application (2019-2030)
5.2.1 Global Mesalazine Revenue by Application (2019-2024)
5.2.2 Global Mesalazine Revenue by Application (2025-2030)
5.2.3 Global Mesalazine Revenue Market Share by Application (2019-2030)
5.3 Global Mesalazine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 PharmaZell
6.1.1 PharmaZell Corporation Information
6.1.2 PharmaZell Description and Business Overview
6.1.3 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 PharmaZell Mesalazine Product Portfolio
6.1.5 PharmaZell Recent Developments/Updates
6.2 Syntese A/S
6.2.1 Syntese A/S Corporation Information
6.2.2 Syntese A/S Description and Business Overview
6.2.3 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Syntese A/S Mesalazine Product Portfolio
6.2.5 Syntese A/S Recent Developments/Updates
6.3 Cambrex Corporation
6.3.1 Cambrex Corporation Corporation Information
6.3.2 Cambrex Corporation Description and Business Overview
6.3.3 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cambrex Corporation Mesalazine Product Portfolio
6.3.5 Cambrex Corporation Recent Developments/Updates
6.4 Divis Laboratories
6.4.1 Divis Laboratories Corporation Information
6.4.2 Divis Laboratories Description and Business Overview
6.4.3 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Divis Laboratories Mesalazine Product Portfolio
6.4.5 Divis Laboratories Recent Developments/Updates
6.5 Chemi SpA
6.5.1 Chemi SpA Corporation Information
6.5.2 Chemi SpA Description and Business Overview
6.5.3 Chemi SpA Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Chemi SpA Mesalazine Product Portfolio
6.5.5 Chemi SpA Recent Developments/Updates
6.6 Ipca Laboratories
6.6.1 Ipca Laboratories Corporation Information
6.6.2 Ipca Laboratories Description and Business Overview
6.6.3 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ipca Laboratories Mesalazine Product Portfolio
6.6.5 Ipca Laboratories Recent Developments/Updates
6.7 Hangzhou Brother
6.6.1 Hangzhou Brother Corporation Information
6.6.2 Hangzhou Brother Description and Business Overview
6.6.3 Hangzhou Brother Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hangzhou Brother Mesalazine Product Portfolio
6.7.5 Hangzhou Brother Recent Developments/Updates
6.8 Lianyungang Fengheng Biopharm
6.8.1 Lianyungang Fengheng Biopharm Corporation Information
6.8.2 Lianyungang Fengheng Biopharm Description and Business Overview
6.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Portfolio
6.8.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
6.9 Lasa Loboratory
6.9.1 Lasa Loboratory Corporation Information
6.9.2 Lasa Loboratory Description and Business Overview
6.9.3 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Lasa Loboratory Mesalazine Product Portfolio
6.9.5 Lasa Loboratory Recent Developments/Updates
6.10 Corden Pharma Bergamo
6.10.1 Corden Pharma Bergamo Corporation Information
6.10.2 Corden Pharma Bergamo Description and Business Overview
6.10.3 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Corden Pharma Bergamo Mesalazine Product Portfolio
6.10.5 Corden Pharma Bergamo Recent Developments/Updates
6.11 Erregierre SpA
6.11.1 Erregierre SpA Corporation Information
6.11.2 Erregierre SpA Mesalazine Description and Business Overview
6.11.3 Erregierre SpA Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Erregierre SpA Mesalazine Product Portfolio
6.11.5 Erregierre SpA Recent Developments/Updates
6.12 CTX Lifescience
6.12.1 CTX Lifescience Corporation Information
6.12.2 CTX Lifescience Mesalazine Description and Business Overview
6.12.3 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CTX Lifescience Mesalazine Product Portfolio
6.12.5 CTX Lifescience Recent Developments/Updates
6.13 Ishita Active Pharma Ingredients
6.13.1 Ishita Active Pharma Ingredients Corporation Information
6.13.2 Ishita Active Pharma Ingredients Mesalazine Description and Business Overview
6.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Ishita Active Pharma Ingredients Mesalazine Product Portfolio
6.13.5 Ishita Active Pharma Ingredients Recent Developments/Updates
6.14 YC Biotech (Jiangsu)
6.14.1 YC Biotech (Jiangsu) Corporation Information
6.14.2 YC Biotech (Jiangsu) Mesalazine Description and Business Overview
6.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 YC Biotech (Jiangsu) Mesalazine Product Portfolio
6.14.5 YC Biotech (Jiangsu) Recent Developments/Updates
6.15 Xinxiang Tianfeng Fine Chemical
6.15.1 Xinxiang Tianfeng Fine Chemical Corporation Information
6.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine Description and Business Overview
6.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio
6.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mesalazine Industry Chain Analysis
7.2 Mesalazine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mesalazine Production Mode & Process
7.4 Mesalazine Sales and Marketing
7.4.1 Mesalazine Sales Channels
7.4.2 Mesalazine Distributors
7.5 Mesalazine Customers
8 Mesalazine Market Dynamics
8.1 Mesalazine Industry Trends
8.2 Mesalazine Market Drivers
8.3 Mesalazine Market Challenges
8.4 Mesalazine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
